European Companies Search Engine
State Aid (€1,000,000 - €2,000,000): Germany - Evaluation plan for the block exempted R&D tax incentive scheme "Forschungszulagengesetz" Sat26 Jun 2023 State Aid Transparency (Tax advantage or tax exemption)
Overview
Text
| Country | Germany |
| Language | German |
| Aid Measure Title | Germany - Evaluation plan for the block exempted R&D tax incentive scheme "Forschungszulagengesetz" (en: Germany — Evaluation plan for the block exempted R & D tax incentive scheme) |
| SA.Number | SA.56245 |
| Ref-no. | TM-11849828 |
| National ID | HRB 21063 |
| Beneficiary National ID Type | Handelsregisternummer |
| Name of the beneficiary | Boehringer Ingelheim International GmbH |
| Beneficiary Type | Only large enterprises |
| Region | Rheinhessen-Pfalz |
| Sector (NACE) | Wholesale of pharmaceutical goods |
| Aid Instrument | Tax advantage or tax exemption |
| Objectives of the Aid | Industrial research (Art. 25(2)(b)) |
| Date of Granting | 26/06/2023 |
| Aid element, expressed as full amount | > 1,000,000 - 2,000,000 EUR |
| Granting Authority Name | FA Bingen-Alzey |
| Co-finance | ✗ |
| Covid-19 | ✗ |
| Entrusted Entity | |
| Financial Intermediaries |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Boehringer Ingelheim International GmbH, Ingelheim a. Rhein, Germany.
The visualizations for "Boehringer Ingelheim International GmbH - State Aid (€1,000,000 - €2,000,000): Germany - Evaluation plan for the block exempted R&D tax incentive scheme "Forschungszulagengesetz""
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
